Loss of adhesion-regulated proteinase production is correlated with invasive activity in oral squamous cell carcinoma
- PMID: 12467066
- DOI: 10.1002/cncr.10997
Loss of adhesion-regulated proteinase production is correlated with invasive activity in oral squamous cell carcinoma
Abstract
Background: Oral squamous cell carcinoma (OSCC) is the most common malignancy of the oral cavity. However, the cellular and biochemical factors that underlie locoregional and distant spread of the disease are poorly understood. Invasion of OSCC requires multiple cellular events including dissolution of cell-cell junctions, basement membrane attachment, extracellular matrix proteolysis, and migration.
Methods: We evaluated these properties in vitro using premalignant gingival keratinocytes (ppl26) and two OSCC lines (SCC15 and SCC68). Expression of adhesion molecules integrins and cadherins, cytoplasmic intermediate filaments (IF) vimentin and keratin as well as matrix degrading proteins were evaluated. Moreover, regulation of protease production by adhesion molecules was tested.
Results: All cell lines contained comparable levels of the epithelial cell-cell adhesion molecule, E-cadherin. Differential expression of cytoplasmic IF was evident between premalignant pp126 cells and OSCC cell lines. Expression levels of the alpha3beta1 integrin, utilized for attachment to laminin-5 and other matrix proteins, was high in SCC68 cells, moderate in SCC15 cells, and low in ppl26 cells. alpha3beta1 integrin clustering up-regulates expression of urinary-type plasminogen activator (uPA) in ppl26 cells via a mechanism involving ERK activation. Both ppl26 and SCC15 cells were responsive to alpha3beta1 clustering, resulting in enhanced uPA expression. However, basal uPA levels were high in SCC68 cells and integrin clustering did not further stimulate uPA production. ERK was constitutively activated in SCC68 cells and treatment of cells with an inhibitor of ERK activation (PD98059) reduced uPA expression. Consistent with the enhanced proteolytic potential, SCC68 cells readily penetrated Matrigel and invasion was blocked by an anticatalytic uPA antibody.
Conclusions: These data suggest that loss of adhesion-regulated proteinase production may lead to elevated pericellular proteinase activity and coincident alterations in cytoskeletal IF protein expression, thereby contributing to the invasive potential of OSCC.
Copyright 2002 American Cancer Society.DOI 10.1002/cncr.10997
Similar articles
-
Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.Oncogene. 2009 Jul 9;28(27):2524-34. doi: 10.1038/onc.2009.105. Epub 2009 May 18. Oncogene. 2009. PMID: 19448673
-
Urinary-type plasminogen activator (uPA) expression and uPA receptor localization are regulated by alpha 3beta 1 integrin in oral keratinocytes.J Biol Chem. 2000 Aug 4;275(31):23869-76. doi: 10.1074/jbc.M000935200. J Biol Chem. 2000. PMID: 10791952
-
Selective changes in laminin adhesion and alpha 6 beta 4 integrin regulation are associated with the initial steps in keratinocyte maturation.Cell Growth Differ. 1996 May;7(5):615-28. Cell Growth Differ. 1996. PMID: 8732671
-
Urinary-type plasminogen activator (uPA) and its receptor (uPAR) in squamous cell carcinoma of the oral cavity.Biochem J. 2007 Oct 15;407(2):153-9. doi: 10.1042/BJ20071037. Biochem J. 2007. PMID: 17880283 Review.
-
Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins.Biol Chem. 2003 Aug;384(8):1119-31. doi: 10.1515/BC.2003.125. Biol Chem. 2003. PMID: 12974381 Review.
Cited by
-
Polypyrimidine tract-binding protein (PTB) differentially affects malignancy in a cell line-dependent manner.J Biol Chem. 2008 Jul 18;283(29):20277-87. doi: 10.1074/jbc.M803682200. Epub 2008 May 22. J Biol Chem. 2008. PMID: 18499661 Free PMC article.
-
Urinary-type plasminogen activator receptor (uPAR) modulates oral cancer cell behavior with alteration in p130cas.Mol Cell Biochem. 2011 Nov;357(1-2):151-61. doi: 10.1007/s11010-011-0885-3. Epub 2011 Jun 1. Mol Cell Biochem. 2011. PMID: 21630091
-
EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression.BMC Cancer. 2012 Mar 23;12:115. doi: 10.1186/1471-2407-12-115. BMC Cancer. 2012. PMID: 22443116 Free PMC article.
-
MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia.Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19300-5. doi: 10.1073/pnas.0803992105. Epub 2008 Nov 25. Proc Natl Acad Sci U S A. 2008. PMID: 19033458 Free PMC article.
-
Prognostic value analysis of urokinase-type plasminogen activator receptor in oral squamous cell carcinoma: an immunohistochemical study.BMC Cancer. 2008 Aug 1;8:220. doi: 10.1186/1471-2407-8-220. BMC Cancer. 2008. PMID: 18673553 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous